Your browser doesn't support javascript.
loading
Machine learning did not beat logistic regression in time series prediction for severe asthma exacerbations.
de Hond, Anne A H; Kant, Ilse M J; Honkoop, Persijn J; Smith, Andrew D; Steyerberg, Ewout W; Sont, Jacob K.
Afiliación
  • de Hond AAH; Department of Information Technology and Digital Innovation, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. a.a.h.de_hond@lumc.nl.
  • Kant IMJ; Clinical AI Implementation and Research Lab, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. a.a.h.de_hond@lumc.nl.
  • Honkoop PJ; Department of Biomedical Data Sciences, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, the Netherlands. a.a.h.de_hond@lumc.nl.
  • Smith AD; Department of Information Technology and Digital Innovation, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
  • Steyerberg EW; Clinical AI Implementation and Research Lab, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, The Netherlands.
  • Sont JK; Department of Biomedical Data Sciences, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, the Netherlands.
Sci Rep ; 12(1): 20363, 2022 11 27.
Article en En | MEDLINE | ID: mdl-36437306
ABSTRACT
Early detection of severe asthma exacerbations through home monitoring data in patients with stable mild-to-moderate chronic asthma could help to timely adjust medication. We evaluated the potential of machine learning methods compared to a clinical rule and logistic regression to predict severe exacerbations. We used daily home monitoring data from two studies in asthma patients (development n = 165 and validation n = 101 patients). Two ML models (XGBoost, one class SVM) and a logistic regression model provided predictions based on peak expiratory flow and asthma symptoms. These models were compared with an asthma action plan rule. Severe exacerbations occurred in 0.2% of all daily measurements in the development (154/92,787 days) and validation cohorts (94/40,185 days). The AUC of the best performing XGBoost was 0.85 (0.82-0.87) and 0.88 (0.86-0.90) for logistic regression in the validation cohort. The XGBoost model provided overly extreme risk estimates, whereas the logistic regression underestimated predicted risks. Sensitivity and specificity were better overall for XGBoost and logistic regression compared to one class SVM and the clinical rule. We conclude that ML models did not beat logistic regression in predicting short-term severe asthma exacerbations based on home monitoring data. Clinical application remains challenging in settings with low event incidence and high false alarm rates with high sensitivity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos